![Dominic Carrano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: - $ as of 2026-06-29
Dominic Carrano is currently Chief Financial Officer at Veradermics, Inc., starting in 2025.
Formerly, Mr. Carrano was Controller at Rallybio Corp.
from 2022 to 2022.
Education includes undergraduate studies at the University of Connecticut.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-02 | 0 ( -.--% ) | - $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| VERADERMICS, INCORPORATED | Director of Finance/CFO | 2023-09-30 |
| Companies | Position | End |
|---|---|---|
| RALLYBIO CORPORATION | Comptroller/Controller/Auditor | 2022-09-30 |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Veradermics, Inc.
 Veradermics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company for treatment of dermatology and aesthetics problems | Health Technology |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
